The Leadership Team at Kymera Therapeutics is responsible for setting the strategic direction and overall vision of the company, guiding the development of innovative biopharmaceuticals. This team oversees regulatory compliance, corporate strategy, and operational excellence, while fostering a culture of collaboration and innovation. Together, they navigate the complexities of clinical development and ensure alignment across departments to advance the company’s mission of harnessing protein degradation for transformative therapies.
Ashwin Gollerkeri
SVP & Head of Development
Brian Albarran
SVP, Corporate Strategy
Bruce Booth
Co-Founder & Chairman
Bruce Jacobs
CFO
Jared Gollob
Chief Medical Officer
Jolly Bhatia
VP, Quality
Karen Weisbach
VP, People & Culture
Kevin Dushney
SVP, IT & Operations
Nello Mainolfi
Co-Founder, President & CEO
Vijay Sabesan
SVP, Technical Operations
View all